RRP22: A novel neural tumor suppressor for astrocytoma

Medical Oncology

Volumn 29, Issue 1, 2012, Pages 332-339

  Chen, Ruokun ^a   Yang, Liang ^a   Fang, Jiasheng ^a   Huo, Lei ^a   Zhang, Mingyu ^a   Chen, Fenghua ^a   Liu, Jinfang ^a   Wu, Jun ^a   Wang, Yanjin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Astrocytoma; Pathological grade; RRP22; Tumor suppressor; U251

Indexed keywords

MESSENGER RNA; PROTEIN RRP22; RAS PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA CELL; CANCER GRADING; CANCER INHIBITION; CANCER INVASION; CELL DEATH; CELL FUNCTION; DOWN REGULATION; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WORLD HEALTH ORGANIZATION;

ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; FLOW CYTOMETRY; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM GRADING; RAS PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84864048576     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9795-6     Document Type: Article

References (20)

1. Fuller GN, Scheithauer BW. The 2007 Revised World Health Organization (WHO) classification of tumours of the central nervous system: newly codified entities. Brain Pathol. 2007; 17(3):304-7. (Pubitemid 47000649)
2. Wang L, et al. Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol. 2006;24(10):1627-32. (Pubitemid 46638787)
3. Lymbouridou R, et al. Down-regulation of K-ras and H-ras in human brain gliomas. Eur J Cancer. 2009;45(7):1294-303.
4. Guha A, et al. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene. 1997;15(23):2755-65. (Pubitemid 28004565)
5. Knobbe CB, Reifenberger J, Reifenberger G. Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas. Acta Neuropathol. 2004;108(6):467-70. (Pubitemid 39534587)
6. Ligon AH, et al. Identification of a novel gene product, RIG, that is down-regulated in human glioblastoma. Oncogene. 1997;14(9): 1075-81. (Pubitemid 27129252)
7. Yu Y, et al. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA. 1999;96(1):214-9. (Pubitemid 29036079)
8. Zucman-Rossi J, Legoix P, Thomas G. Identification of new members of the Gas2 and Ras families in the 22q12 chromosome region. Genomics 1996 Dec 15 cited 383; 1996/12/15:247-54. (Pubitemid 27030111)
9. Elam C, et al. RRP22 is a farnesylated, nucleolar, Ras-related protein with tumor suppressor potential. Cancer Res. 2005;65(8): 3117-25. (Pubitemid 40524592)
10. Prigent SA, et al. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway. J Biol Chem. 1996;271(41):25639-45. (Pubitemid 26337944)
11. Cloughesy TF, et al. Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American brain tumor consortium study. J Clin Oncol. 2006;24(22):3651-6. (Pubitemid 46630540)
12. Lustig R, et al. Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease. Neuro Oncol. 2008;10(6):1004-9.
13. Lu W, et al. Suppression of invasion in human U87 glioma cells by adenovirus-mediated co-transfer of TIMP-2 and PTEN gene. Cancer Lett. 2004;214(2):205-13. (Pubitemid 39207982)
14. Lakka SS, et al. Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene. 2002;21(52):8011-9. (Pubitemid 35434187)
15. Van Delft MF, et al. Apoptosis and non-inflammatory phagocytosis can be induced by mitochondrial damage without caspases. Cell Death Differ. 2010;17(5):821-32.
16. Tait SW, Green DR. Caspase-independent cell death: leaving the set without the final cut. Oncogene. 2008;27(50):6452-61.
17. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science. 2004;305(5684):626-9. (Pubitemid 39006738)
18. Noutsopoulos D, et al. VL30 retrotransposition signals activation of a caspase-independent and p53-dependent death pathway associated with mitochondrial and lysosomal damage. Cell Res. 2010;20(5):553-62.
19. Xiang J, Chao DT, Korsmeyer SJ. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci USA. 1996;93(25):14559-63. (Pubitemid 26419006)
20. Levine B, Klionsky DJ. Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev Cell. 2004;6(4):463-77. (Pubitemid 38456176)